of India Ltd (SAIL) 
The benchmark Sensex stretched its previous day's gain and climbed up by more
New Delhi: Global telecom networking major, BT is anticipating revenue o
New Delhi: To swell its air and ground infrastructure, integrated express courier and package distribution company, Blue Dart Express has decided to invest Rs. 1,000 crore in the next five to eight years. The investment will be funded through internal accruements. 
New Delhi: Cairn India has received government’s authorization for laying a pipel
New Delhi: The Supreme Court, on Tuesday, allowed a divisive Norwegian cruise liner to be demolished despite more than a year of objections by conservationists who said that the ship has toxic waste.ICICI Securities has maintained a HOLD rating on Siemens Ltd., with a 12-month target price of Rs 4,190, implying about 12% upside from the current market price of Rs 3,750.
News in Focus
Featured, India Business, Analyst View, Stock Markets, Engineering Sector, ICICI Direct, India, Siemens
ICICI Securities has reiterated a BUY recommendation on Kajaria Ceramics, setting a target price of Rs 1,300, implying about 17% upside from the current market price of Rs 1,114 over a 12-m
ICICI Securities has reiterated a Buy call on Lemon Tree Hotels Ltd., with a revised target price of Rs 142, implying 29% upside from the CMP of Rs 110 over a 12-month horizon.
Featured, India Business, Company Results, Analyst View, Greenpanel Industries, India, Prabhudas Lilladher
Prabhudas Lilladher has retained a BUY recommendation on Greenpanel Industries, with a target price of Rs 332 against a current market price of Rs 186, signaling substantial upside
Motilal Oswal has reiterated a BUY call on NMDC and pegged a target price of Rs 106, implying about 15% upside from the current market price of Rs 92.
IDBI Capital has suggested BUY Call for Lemon Tree Hotels with Target Price at Rs 165 compared to current price ranging between Rs 110-115.
Main Regional Stories
Axis Securities has upgraded Asian Paints to a BUY rating with a revised target price of Rs 3,130 per share, implying an upside potential of approximately 17% from the current market price of Rs 2,672.
Featured, India Business, Analyst View, Glenmark Pharmaceuticals, India, Motilal Oswal, Pharmaceutical Sector
Motilal Oswal has reiterated a BUY call on Glenmark Pharma, with a target price of Rs2,610 and an implied upside of 19% from the current market price of Rs2,201.
India’s brokerage war in 2026 is no longer about who is cheapest. It is now about who offers the deepest ecosystem, the smartest tools, and the clearest fit for different kinds of traders.
India’s economy has long balanced rapid growth ambitions with a heavy dependence on imported energy.
